Quizartinib Boosts AML Survival, Regardless of SCT ...Middle East

Medscape - News
Adding quizartinib to standard induction chemotherapy significantly improves overall survival in patients with newly diagnosed acute myeloid leukemia regardless of prior stem cell transplantation. MDedge News

Hence then, the article about quizartinib boosts aml survival regardless of sct was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Quizartinib Boosts AML Survival, Regardless of SCT )

Apple Storegoogle play

Last updated :

Also on site :